Vesicular drug delivery systems as theranostics in COVID-19.

Satija, Saurabh; Mehta, Meenu; Sharma, Mousmee; Prasher, Parteek; Gupta, Gaurav; Chellappan, Dinesh K; Dua, Kamal

Satija, Saurabh; Mehta, Meenu; Sharma, Mousmee; Prasher, Parteek; Gupta, Gaurav; Chellappan, Dinesh K; Dua, Kamal.

Satija S; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
Mehta M; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara-144411, Punjab, India.
Sharma M; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
Prasher P; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara-144411, Punjab, India.
Gupta G; Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia.
Chellappan DK; Department of Chemistry, Uttaranchal University, Dehradun, 248007, India.
Dua K; Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India.

Future Med Chem ; 12(18): 1607-1609, 2020 09.

Article in English | MEDLINE | ID: covidwho-615629

Subject(s)

Coronavirus Infections/diagnosis; Coronavirus Infections/drug therapy; Drug Delivery Systems; Pneumonia, Viral/diagnosis; Pneumonia, Viral/drug therapy; Theranostic Nanomedicine; Animals; COVID-19; Drug Carriers; Humans; Pandemics

Keywords

COVID-19; theranostics; vesicular drug delivery

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Drug Delivery Systems / Coronavirus Infections / Theranostic Nanomedicine Type of study: Diagnostic study Limits: Animals / Humans Language: English Journal: Future Med Chem Year: 2020 Document Type: Article Affiliation country: Fmc-2020-0149

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google